Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.

Abstract : Nephrogenic systemic fibrosis (NSF) has been related to the use of gadolinium-based contrast agents (GBCAs) in patients undergoing dialysis. The Prospective Fibrose Nephrogénique Systémique study, a French prospective study supported by the French drug regulatory agency (Agence Nationale de Sécurité du Médicament) and the French Societies of Nephrology, Dermatology, and Radiology, aimed at determining the incidence of NSF in patients undergoing long-term dialysis.
Type de document :
Article dans une revue
Investigative Radiology, Lippincott, Williams & Wilkins, 2014, 49 (2), pp.109-15. 〈10.1097/RLI.0000000000000000〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-01102645
Contributeur : Jean-Yves Gauvrit <>
Soumis le : mardi 13 janvier 2015 - 11:54:28
Dernière modification le : mercredi 16 mai 2018 - 11:24:04

Identifiants

Citation

Sabine Amet, Vincent Launay-Vacher, Olivier Clément, Camille Frances, Aurore Tricotel, et al.. Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.. Investigative Radiology, Lippincott, Williams & Wilkins, 2014, 49 (2), pp.109-15. 〈10.1097/RLI.0000000000000000〉. 〈inserm-01102645〉

Partager

Métriques

Consultations de la notice

339